Use of metformin in the setting of mild-to-moderate renal insufficiency

doi:10.2337/dc10-2361

Review

. 2011 Jun;34(6):1431-7.

doi: 10.2337/dc10-2361.

Use of metformin in the setting of mild-to-moderate renal insufficiency

Kasia J Lipska¹, Clifford J Bailey, Silvio E Inzucchi

Affiliations

PMID: 21617112
PMCID: PMC3114336
DOI: 10.2337/dc10-2361

Review

Use of metformin in the setting of mild-to-moderate renal insufficiency

Kasia J Lipska et al. Diabetes Care. 2011 Jun.

. 2011 Jun;34(6):1431-7.

doi: 10.2337/dc10-2361.

Authors

Kasia J Lipska¹, Clifford J Bailey, Silvio E Inzucchi

Affiliation

¹ Robert Wood Johnson Clinical Scholars Program, Yale University School of Medicine, New Haven, Connecticut, USA.

PMID: 21617112
PMCID: PMC3114336
DOI: 10.2337/dc10-2361

No abstract available

PubMed Disclaimer

Comment in

El uso de metformina en el contexto de insuficiencia renal leve o moderada.
Gómez-Huelgas R; Grupo de Diabetes y Obesidad de la Sociedad Española de Medicina Interna. Gómez-Huelgas R, et al. Rev Clin Esp. 2012 Feb;212(2):105. doi: 10.1016/j.rce.2011.09.005. Rev Clin Esp. 2012. PMID: 22413134 Spanish. No abstract available.

Cited by

How to improve drug dosing for patients with renal impairment in primary care - a cluster-randomized controlled trial.
Erler A, Beyer M, Petersen JJ, Saal K, Rath T, Rochon J, Haefeli WE, Gerlach FM. Erler A, et al. BMC Fam Pract. 2012 Sep 6;13:91. doi: 10.1186/1471-2296-13-91. BMC Fam Pract. 2012. PMID: 22953792 Free PMC article. Clinical Trial.
Metformin: an old but still the best treatment for type 2 diabetes.
Rojas LB, Gomes MB. Rojas LB, et al. Diabetol Metab Syndr. 2013 Feb 15;5(1):6. doi: 10.1186/1758-5996-5-6. Diabetol Metab Syndr. 2013. PMID: 23415113 Free PMC article.
[Geriatric aspects for the management of diabetes mellitus].
Huber J, Smeikal M, Lechleitner M, Fasching P. Huber J, et al. Wien Klin Wochenschr. 2016 Apr;128 Suppl 2:S124-30. doi: 10.1007/s00508-016-0955-3. Wien Klin Wochenschr. 2016. PMID: 27052230 Review. German.
Update on the treatment of type 2 diabetes mellitus.
Marín-Peñalver JJ, Martín-Timón I, Sevillano-Collantes C, Del Cañizo-Gómez FJ. Marín-Peñalver JJ, et al. World J Diabetes. 2016 Sep 15;7(17):354-95. doi: 10.4239/wjd.v7.i17.354. World J Diabetes. 2016. PMID: 27660695 Free PMC article. Review.
Safety events in kidney transplant recipients: results from the folic Acid for vascular outcome reduction in transplant trial.
Weir MR, Gravens-Muller L, Costa N, Ivanova A, Manitpisitkul W, Bostom AG, Diamantidis CJ; FAVORIT Study Investigators. Weir MR, et al. Transplantation. 2015 May;99(5):1003-8. doi: 10.1097/TP.0000000000000454. Transplantation. 2015. PMID: 25393158 Free PMC article.

See all "Cited by" articles

References

1. Herrington WG, Levy JB. Metformin: effective and safe in renal disease? Int Urol Nephrol 2008;40:411–417 - PubMed
1. McCormack J, Johns K, Tildesley H. Metformin’s contraindications should be contraindicated. CMAJ 2005;173:502–504 - PMC - PubMed
1. Lalau JD. Lactic acidosis induced by metformin: incidence, management and prevention. Drug Saf 2010;33:727–740 - PubMed
1. Bailey CJ. Metformin: effects on micro and macrovascular complications in type 2 diabetes. Cardiovasc Drugs Ther 2008;22:215–224 - PubMed
1. Gerstein HC, Miller ME, Byington RP, et al. ; Action to Control Cardiovascular Risk in Diabetes Study Group Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545–2559 - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information

[1] Herrington WG, Levy JB. Metformin: effective and safe in renal disease? Int Urol Nephrol 2008;40:411–417 - PubMed

[2] Herrington WG, Levy JB. Metformin: effective and safe in renal disease? Int Urol Nephrol 2008;40:411–417 - PubMed

[3] McCormack J, Johns K, Tildesley H. Metformin’s contraindications should be contraindicated. CMAJ 2005;173:502–504 - PMC - PubMed

[4] McCormack J, Johns K, Tildesley H. Metformin’s contraindications should be contraindicated. CMAJ 2005;173:502–504 - PMC - PubMed

[5] Lalau JD. Lactic acidosis induced by metformin: incidence, management and prevention. Drug Saf 2010;33:727–740 - PubMed

[6] Lalau JD. Lactic acidosis induced by metformin: incidence, management and prevention. Drug Saf 2010;33:727–740 - PubMed

[7] Bailey CJ. Metformin: effects on micro and macrovascular complications in type 2 diabetes. Cardiovasc Drugs Ther 2008;22:215–224 - PubMed

[8] Bailey CJ. Metformin: effects on micro and macrovascular complications in type 2 diabetes. Cardiovasc Drugs Ther 2008;22:215–224 - PubMed

[9] Gerstein HC, Miller ME, Byington RP, et al. ; Action to Control Cardiovascular Risk in Diabetes Study Group Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545–2559 - PMC - PubMed

[10] Gerstein HC, Miller ME, Byington RP, et al. ; Action to Control Cardiovascular Risk in Diabetes Study Group Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545–2559 - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Use of metformin in the setting of mild-to-moderate renal insufficiency

Affiliation

Use of metformin in the setting of mild-to-moderate renal insufficiency

Authors

Affiliation

Comment in

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Comment in

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical